704 BIOLOGY OF PNEUMOCOCCUS 



593. Hari.ey, D. Study of pneumococcal allergy, anaphylaxis and im- 

 munity. J. Path. & Bact., 41 (3) : 491, Nov. 1935 343 



594. Harris, A. B. Observations on the therapeutic value of the pneu- 

 mococcus vaccine in the treatment of pneumonia and some of its 

 complications. Brit. M. J., 1:1530, June 26, 1909. 



595. Harris, A. L., Sugg, J. Y., and Neill, J. M. Studies on immuno- 

 logical relationships among the pneumococci. II. A comparison of 

 the antibody responses of mice and of rabbits to immunization 

 with typical Type III pneumococci and to immunization with a 

 related strain. J. Exper. Med., 47(6) : 933, June 1928 Ill 



596. Hartley, P., and Smith, W. A proposed international standard 

 for antipneumococcus serum (Type I). Quart. Bull, of the Health 

 Organisation of the League of Nations, 4(spec. no.): 48, Jan. 1935. 



569, 576, 586 



597. Hartley, P., and Smith, W. A proposed international standard 

 for antipneumococcus serum (Type II). Quart. Bull, of the 

 Health Organisation of the League of Nations, 4(spec. no.): 63, 



Jan. 1935 569 



598. Hartman, C. C. Serum studies in pneumonia. The antigenic 

 properties of fibrin (exudate) to serum. J. Infect. Dis., 13(1): 



69, July 1913 337 



599. Hartman, C. C. The antigenic properties of the constituents of 

 the pneumonic exudate. Serum studies in pneumonia. II. J. In- 

 fect. Dis., 13(3) :499, Nov. 1913 527 



600. Hecht, A. F. Die Haut als Testobjekt. Wien: J. Springer, 1925. 



601. Heffron, R. Pneumonia with special reference to pneumococcus 

 lobar pneumonia. New York: The Commonwealth Fund. In 

 preparation 214, 216, 217, 503, 507, 559 



602. Heffron, R., and Varley, F. M. A study of lobar pneumonia in 

 Massachusetts: Methods and results of pneumococcus type deter- 

 mination. 1931-32. Am. J. Pub. Health, 22(12): 1230, Dec. 1932. 129 



603. Heidei.berger, M. Contributions of chemistry to the knowledge 

 of immune processes. Medicine, 12(3) :279, Sept. 1923. 



604. Heidelberger, M. The chemical nature of immune substances. 

 Physiol. Rev., 7(1): 107, Jan. 1927 244,247 



605. Heidelberger, M. Immunologically specific polysaccharides. 

 Chem. Rev., 3(4) :403, Jan. 1927 244, 247, 250 



606. Heidelberger, M., and Avery, O. T. The soluble specific sub- 

 stance of pneumococcus. J. Exper. Med., 38(1): 73, July, 1923. 



238, 243, 370, 582 



607. Heidelberger, M., and Avery, O. T. The soluble specific sub- 

 stance of pneumococcus. Second paper. J. Exper. Med., 40(3): 



301, Sept. 1924 370 



608. Heidelberger, M., Avery, O. T., and Goebel, W. F. A "soluble 

 specific substance" derived from gum arabic. J. Exper. Med., 49 



(5) :847, May 1929 261 



609. Heidelberger, M., and Goebel, W. F. The soluble specific sub- 

 stance of pneumococcus. IV. On the nature of the specific poly- 



